It has been reported that a high expression of SOX2 was significantly associated with poorer survival in node-negative OSCC [18], while others [17,26,37] found that a high expression of SOX2 correlated with lymph node metastasis. Here, SOX2 is linked to metastatic malignant neoplasm in the lymph nodes.